Results 61 to 70 of about 2,971,946 (381)

A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma

open access: yes, 1996
Background The median survival of patients with myeloma after conventional chemotherapy is three years or less. Promising results have been reported with high-dose therapy supported by autologous bone marrow transplantation.
M. Attal   +11 more
semanticscholar   +1 more source

Graft-versus-leukemia reactions after bone marrow transplantation.

open access: yesBlood, 1990
To determine whether graft-versus-leukemia (GVL) reactions are important in preventing leukemia recurrence after bone marrow transplantation, we studied 2,254 persons receiving HLA-identical sibling bone marrow transplants for acute myelogenous leukemia (
M. Horowitz   +9 more
semanticscholar   +1 more source

New Automatized Method of 3D Multiculture Viability Analysis Based on Confocal Imagery: Application to Islets and Mesenchymal Stem Cells Co-Encapsulation

open access: yesFrontiers in Endocrinology, 2018
Co-encapsulation of pancreatic islets with mesenchymal stem cells in a three-dimensional biomaterial’s structure is a promising technique to improve transplantation efficacy and to decrease immunosuppressant therapy.
Clovis Chabert   +21 more
doaj   +1 more source

Angiography of liver transplantation patients [PDF]

open access: yes, 1985
Over 45 months, 119 angiographic examinations were performed in 95 patients prior to liver transplantation, and 53 examinations in 44 patients after transplantation.
Bron, KM   +9 more
core   +1 more source

Targeting Enclysis in Liver Autoimmunity, Transplantation, Viral Infection and Cancer

open access: yesFrontiers in Immunology, 2021
Persistent liver inflammation can lead to cirrhosis, which associates with significant morbidity and mortality worldwide. There are no curative treatments beyond transplantation, followed by long-term immunosuppression.
Yara O. Aghabi   +5 more
doaj   +1 more source

Evaluation of protocol before transplantation and after reperfusion biopsies from human orthotopic liver allografts: Considerations of preservation and early immunological injury [PDF]

open access: yes, 1990
Light microscopic, immunohistochemical and ultrastructural analysis of protocol before transplantation and after reperfusion biopsy specimens from 87 randomly selected patients was performed to assess the contribution of preservation and immunological ...
Bassi   +39 more
core   +1 more source

Leveraging current insights on IL‐10‐producing dendritic cells for developing effective immunotherapeutic approaches

open access: yesFEBS Letters, EarlyView.
In vivo IL‐10 produced by tissue‐resident tolDC is involved in maintaining/inducing tolerance. Depending on the agent used for ex vivo tolDC generation, cells acquire common features but prime T cells towards anergy, FOXP3+ Tregs, or Tr1 cells according to the levels of IL‐10 produced. Ex vivo‐induced tolDC were administered to patients to re‐establish/
Konstantina Morali   +3 more
wiley   +1 more source

Infection in Organ Transplantation

open access: yesAmerican Journal of Transplantation, 2017
The prevention, diagnosis, and management of infectious disease in transplantation are major contributors to improved outcomes in organ transplantation. The risk of serious infections in organ recipients is determined by interactions between the patient ...
J. Fishman
semanticscholar   +1 more source

FoxO1 signaling in B cell malignancies and its therapeutic targeting

open access: yesFEBS Letters, EarlyView.
FoxO1 has context‐specific tumor suppressor or oncogenic character in myeloid and B cell malignancies. This includes tumor‐promoting properties such as stemness maintenance and DNA damage tolerance in acute leukemias, or regulation of cell proliferation and survival, or migration in mature B cell malignancies.
Krystof Hlavac   +3 more
wiley   +1 more source

Antigen-Specific Regulatory T Cell Therapy in Autoimmune Diseases and Transplantation

open access: yesFrontiers in Immunology, 2021
Regulatory T (Treg) cells are a heterogenous population of immunosuppressive T cells whose therapeutic potential for the treatment of autoimmune diseases and graft rejection is currently being explored.
Claudia Selck   +1 more
doaj   +1 more source

Home - About - Disclaimer - Privacy